A retrospective clinical review of drug induced interstitial lung disease at a tertiary cancer centre

F. Walker (Manchester, United Kingdom), R. Broadbent (Manchester, United Kingdom), B. Taylor (Manchester, United Kingdom), S. Tenant (Manchester, United Kingdom), K. Linton (Manchester, United Kingdom)

Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Session: CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Session type: Poster Discussion
Number: 3662
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Walker (Manchester, United Kingdom), R. Broadbent (Manchester, United Kingdom), B. Taylor (Manchester, United Kingdom), S. Tenant (Manchester, United Kingdom), K. Linton (Manchester, United Kingdom). A retrospective clinical review of drug induced interstitial lung disease at a tertiary cancer centre. 3662

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The role of chemotherapy re-challenge in non small cell lung cancer. A retrospective study in a tertiary general hospital and thoracic center
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011

Multidisciplinary management of interstitial lung diseases in a tertiary centre: A prospective study.
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018

Retrospective review of a novel clinical service and pathway for patients with pulmonary nodules
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016

A review of patients following a diagnosis of unclassified interstitial lung disease (ILD) at a tertiary centre
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020


A prospective observational study on 10770 patients with lung disorder visiting the pulmonary specialist in a regional hospital, with special emphasis on 703 patients with lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 674s
Year: 2004

A case series study on re-treatment to lung cancer after drug-induced interstitial lung disease
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018



Multidisciplinary diagnosis of interstitial lung disease: a retrospective analysis
Source: International Congress 2019 – Medical education
Year: 2019

A single-centre retrospective study to phenotype unclassifiable interstitial lung disease
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020


A retrospective cohort study of interstitial lung diseases in Denmark
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012

A retrospective study of lung cancer in young patients
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011


Early symptoms in suspected lung cancer: a prospective cohort study
Source: Eur Respir J 2001; 18: Suppl. 33, 64s
Year: 2001

A retrospective analysis of patient presentation to primary and secondary care prior to subsequent late stage lung cancer diagnosis
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011


Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in extensive disease small cell lung cancer (ED SCLC)
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019


Videothoracoscopic lung biopsy (VATS-LB) in the diagnosis of diffuse interstitial lung disease (DILD) and evaluation of an outpatient surgical approach. A prospective multicentric study
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008


Pirfenidone as a treatment for asbestos-related lung fibrosis? A retrospective case series
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018

Pulmonary rehabilitation after radically treated lung cancer patients: a pilot study
Source: Annual Congress 2008 - Pulmonary rehabilitation for non-COPD and severe COPD; field exercise testing
Year: 2008

Nutrition-related factors associated with waiting list mortality in patients with interstitial lung disease: a retrospective cohort study
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019


Interstitial lung disease in childhood. A clinical review
Source: Eur Respir J 2004; 24: Suppl. 48, 624s
Year: 2004

Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review
Source: ERJ Open Res, 7 (1) 00235-2020; 10.1183/23120541.00235-2020
Year: 2021



A retrospective study of the cause and impact of delayed diagnosis of lung cancer (LC)
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008